Daihan Pharmaceutical Chairman Lee Yoon Woo Raises Stake to 25.05%

• Chairman Lee Yoon Woo increased his stake in Daihan Pharmaceutical to 25.05% from 25.04%.
• Open-market purchases of 1,002 common shares on Nov. 2-6, 2026, lifted his holdings to 1,503,216 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daihan Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106000294), on November 06, 2026, and is solely responsible for the information contained therein.